• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYLIS MEDICALE CIE INC VERSACROSS CONNECT LAAC ACCESS SOLUTION; DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYLIS MEDICALE CIE INC VERSACROSS CONNECT LAAC ACCESS SOLUTION; DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION Back to Search Results
Model Number VXAK0003
Medical Device Problem Code Material Perforation (2205)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 12/13/2024
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that a versacross connect laac access solution was selected for use during a watchman procedure.During preparation, upon opening the packaging for the versacross connect it was noted that the distal tip of the dilator was damaged, like a rip.Thus, a new kit was opened to be used.The procedure was completed successfully.No patient complications were reported.Product return is expected.It says that the material was buckled, prior to advance into the sheath.No other issues were reported.
 
Additional Manufacturer Narrative
The device has not been received for analysis.Upon receipt and completion of the failure analysis of the complaint device, if there is any further relevant information from that review, a supplemental medwatch will be filed.
 
Additional Manufacturer Narrative
The device has been received for analysis.Upon receipt at our post market quality assurance laboratory, the dilator was visually inspected and confirmed to have a tip and taper damage, aligned with tip damage.Also, a minor scrapping was noted along its distal end.Additionally, the device passed flushing tests.The reported allegation of dilator tip damage was confirmed based on the product investigation.
 
Event or Problem Description
It was reported that a versacross connect laac access solution was selected for use during a watchman procedure.During preparation, upon opening the packaging for the versacross connect it was noted that the distal tip of the dilator was damaged, like a rip.Thus, a new kit was opened to be used.The procedure was completed successfully.No patient complications were reported.Product return is expected.It says that the material was buckled, prior to advance into the sheath.No other issues were reported.The device has returned for analysis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERSACROSS CONNECT LAAC ACCESS SOLUTION
Common Device Name
DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION
Manufacturer (Section D)
BAYLIS MEDICALE CIE INC
5959 trans-canada highway
montreal H4T 1 A1
CA  H4T 1A1
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
zona franca la lima
cartgo, 03 30106
CS   30106
Manufacturer Contact
mary crawford
4100 hamline avenue north
dc a330
saint paul, MN 55112
6514400979
MDR Report Key21103464
Report Number2124215-2024-83107
Device Sequence Number8637387
Product Code DRE
UDI-Device Identifier00685447018346
UDI-Public00685447018346
Combination Product (Y/N)N
Initial Reporter StateIA
Initial Reporter CountryUS
PMA/510(K) Number
K220414
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 03/20/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberVXAK0003
Device Catalogue NumberVXAK0003
Device Lot Number0034775459
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/13/2024
Supplement Date Received by Manufacturer03/07/2025
Initial Report FDA Received Date01/08/2025
Supplement Report FDA Received Date03/20/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured04/02/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-